Using AmpliSeq for Illumina Custom RNA panels for targeted gene expression profiling

27 November 2019

Jeff Tsai, a senior scientist in product development at Illumina, and his team set up a study to evaluate how the recently launched AmpliSeq™ for Illumina Custom RNA assay compares to qPCR for analyzing differential gene expression. Learn about their findings and discover the benefits of this targeted RNA-seq approach. For more information on AmpliSeq, please visit: Download the PDF: Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on